You’re using a public version of DrugPatentWatch with 1 free search available | Register to unlock more free searches. CREATE FREE ACCOUNT

Serving leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim

Last Updated: September 27, 2023

Patent: 9,951,010

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 9,951,010
Title:Compounds as CRTH2 antagonist and uses thereof
Abstract: The compounds of Formula (I) which can be used as CRTH2 receptor antagonists are provided. The compounds of Formula (I) can be used in the treatment and prevention of asthma, allergic rhinitis and atopic dermatitis, as well as other diseases mediated by prostaglandin D2 (PGD2) at the CRTH2 receptor. ##STR00001##
Inventor(s): Zhang; Yingjun (Dongguan, CN), Yu; Tianzhu (Dongguan, CN), Liu; Bing (Dongguan, CN), Zhang; Xiangyu (Dongguan, CN), Zhang; Shiguo (Dongguan, CN), Cheng; Changchung (Dongguan, CN), Zhang; Jiancun (Dongguan, CN)
Assignee: SUNSHINE LAKE PHARMA CO., LTD. (Dongguan, Guangdong, CN)
Application Number:15/504,018
Patent Claims:see list of patent claims

Details for Patent 9,951,010

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Genentech, Inc. XOLAIR omalizumab For Injection 103976 06/20/2003 ⤷  Try a Trial 2034-09-13
Genentech, Inc. XOLAIR omalizumab Injection 103976 09/28/2018 ⤷  Try a Trial 2034-09-13
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.